Why Bristol Myers Squibb Is a Table-Pounding Buy
Perhaps not surprisingly, the all-time great investor Warren Buffett has one of the best quotes that aptly summarizes the aim of value investing. In his 2008 letter to Berkshire Hathaway's shareholders, he wrote, "Long ago, Ben Graham taught me that - Price is what you pay; value is what you get."
True to the value-investing approach of finding high-quality stocks trading at unjustifiably low prices, I will discuss three reasons why the pharma stock Bristol Myers Squibb (NYSE: BMY) is a strong buy for value and income investors alike.
Image Source: Getty Images.
Source Fool.com
